High-dose cyclophosphamide as an effective therapy for a patient with refractory multiple myeloma relapsing after autologous stem cell transplantation

Internal Medicine

Volumn 44, Issue 5, 2005, Pages 471-475

  Yagisawa, Kumiko ^a,b   Aiba, Akiko ^a   Momoi, Akihito ^a   Tsukada, Nobuhiro ^a   Nikkuni, Koji ^a   Aoki, Sadao ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

High dose cyclophosphamide; Hypercalcemia; Incadronate; Multiple myeloma

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CARBOPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIURETIC AGENT; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; INCADRONIC ACID; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MELPHALAN; MESNA; NITROGEN; PREDNISOLONE; RANIMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE; UREA; VINCRISTINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; BONE PAIN; CALCIUM BLOOD LEVEL; CANCER RELAPSE; CASE REPORT; CREATININE CLEARANCE; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; HYPERCALCEMIA; ILIAC BONE; LEUKOCYTE COUNT; MULTIPLE MYELOMA; POLYURIA; PROTEIN BLOOD LEVEL; REFRACTORY PERIOD; SIDE EFFECT; SOMNOLENCE; SPINE METASTASIS; THIRST; THROMBOCYTE COUNT; TUMOR VOLUME; UREA NITROGEN BLOOD LEVEL;

ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILIUM; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM RECURRENCE, LOCAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SKULL; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, AUTOLOGOUS;

EID: 21244472307     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.471     Document Type: Article

References (13)

1. Kalant H, Roschlau W. Principles of Medical Pharmacology. 6th ed. Oxford University Press, Oxford, 1998: 760-763.
2. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic: stem cells for autotransplantation. Lancet 2: 580-585, 1989.
3. 2 plus rh-G-CSF for mobilization of circulating progenitor cells in malignant lymphomas. Int J Artif Organs Suppl 5: 30-34, 1993.
4. Santos GW, Tutschka PJ, Brookmever R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309: 1347-1353, 1983.
5. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70: 1382-1388, 1987.
6. Appelbaum FR, Barrall J, Storb R, et al. Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. Ann Intern Med 112: 590-597, 1990.
7. Lenhard RE Jr, Oken MM, Barnes JM, Humphery RL, Glick JH, Silverstein MN. High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma. Cancer 53: 1456-1460, 1984.
8. Hahn T, Wingard JR, Anderson KC, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of mutiple myeloma: an evidence-based review. Biol Blood Marrow Transplant 9: 4-37, 2003.
9. Meloni G, Capria S, Trasarti S, et al. High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study. Bone Marrow Transplant 26: 1045-1049, 2000.
10. Terpos E, Palermos J, Tsionos K, et al. Effect of pamidronate administration on makers of bone turnover and disease activity in multiple myeloma. Eur J Haematol 62: 331-336, 2000.
11. Gottdiener JS, Applebaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141: 758-763, 1981.
12. Watanabe A, Kameda A, Suda Y. Hemorrhagic cystitis induced by cyclophosphamide(Endoxan). Nippon Rinsho 24: 1525-1529, 1966.
13. Anderson EE, Cobb OE, Glenn JF. Cyclophosphamide hemorrhagic cystitis. J Urol 97: 857-858, 1967.